{"id":9863,"date":"2019-05-21T13:57:46","date_gmt":"2019-05-21T13:57:46","guid":{"rendered":"http:\/\/www.sib.it\/?p=9863"},"modified":"2019-05-22T08:06:22","modified_gmt":"2019-05-22T08:06:22","slug":"brevetti-farmaceutici-vigore-entro-1-luglio-2019-la-deroga-al-certificato-complementare-protezione","status":"publish","type":"post","link":"https:\/\/www.sib.it\/en\/flash-news\/italiano-brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/","title":{"rendered":"SPC waiver finalised and expected to enter into force by 1 July 2019"},"content":{"rendered":"

The new \u201cSPC waiver\u201d regulation, that will allow EU-based biosimilar and generic manufacturers to start making medicinal products protected by an SPC before expiry of the SPC at certain conditions, became final on 14 May after adoption by the Council of the EU and is expected to enter into force by 1 July 2019.<\/em>\"deroga<\/p>\n

Formal adoption by Council of the European Union on 14 May 2019 has finalised a new regulation that introduces into European Union law a manufacturing waiver for Supplementary Protection Certificates (SPCs). The European Parliament had approved the text of the new regulation less than a month earlier, on 17 April 2019.<\/p>\n

The aim of the SPC waiver, according to official statements, is to boost the competitiveness of EU-based biosimilar and generic companies.<\/p>\n

What has changed?<\/span><\/h2>\n

The adopted regulation<\/a> has not changed much since the original proposal tabled in May 2018<\/a>.<\/p>\n

In essence, the includes further measures to ensure respect of the waiver\u2019s limits.<\/p>\n

What will the waiver apply to?<\/span><\/h2>\n

The waiver will apply to the production in the territory of the European Union, during the term of validity of the SPC, of generic or biosimilar medicines intended exclusively for export to countries<\/strong> outside the European Union where protection of the original medicine does not exist or has expired<\/strong>.<\/p>\n

It will also apply to the stockpiling<\/strong> the product in European Union territory during the last 6 months of the term of the SPC to allow day-1-launch<\/strong> of the generic or biosimilar product on the European Union market as soon as the SPC expires.<\/p>\n

Which SPCs will the waiver apply to?<\/span><\/h2>\n

For three years after its entry force, the new regulation will affect only SPCs that are applied for on or after the date of entry into force of the regulation. As from the fourth year, the regulation will also affect SPCs applied for before the entry into force of the regulation, but which have become effective after the entry into force of the regulation.<\/p>\n

Waiver conditions<\/span><\/h2>\n

3 months at the latest before starting production, the manufacturer must notify the SPC holder and the national patent office that granted the SPC.<\/p>\n

An \u201cEU export\u201d logo must be affixed to the packaging of products made for the purpose of export to countries outside the European Union.<\/p>\n

The manufacturer must inform its supply chain that the product is made under the waiver and is intended either for export outside the European Union or for day-1-launch in the EU market.<\/p>\n

When will the new regulation enter into force?<\/span><\/h2>\n

The regulation is yet to be published in the Official Journal of the European Union. According to a release<\/a> of the Council of the European Union, the regulation is expected to enter into force by 1 July 2019.<\/p>\n

 <\/p>\n

Related articles<\/em><\/p>\n

Flash news – SPC waiver: draft EU regulation takes a step forward<\/a><\/p>\n

Flash news \u2013 European Commission proposes SPC waiver<\/a><\/p>","protected":false},"excerpt":{"rendered":"

The new \u201cSPC waiver\u201d regulation, that will allow EU-based biosimilar and generic manufacturers to start making medicinal products protected by an SPC before expiry of the SPC at certain conditions, became final on 14 May after adoption by the Council of the EU and is expected to enter into force by 1 July 2019. Formal […]<\/p>\n","protected":false},"author":4,"featured_media":7011,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[13],"tags":[],"acf":[],"yoast_head":"\nBrevetti farmaceutici, deroga al certificato complementare di protezione<\/title>\n<meta name=\"description\" content=\"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brevetti farmaceutici, deroga al certificato complementare di protezione\" \/>\n<meta property=\"og:description\" content=\"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-21T13:57:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-22T08:06:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"424\" \/>\n\t<meta property=\"og:image:height\" content=\"283\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Ercoli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sib.it\/#website\",\"url\":\"https:\/\/www.sib.it\/\",\"name\":\"\",\"description\":\"Intellectual Property since 1882\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sib.it\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg\",\"contentUrl\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg\",\"width\":424,\"height\":283,\"caption\":\"deroga al certificato complementare di protezione\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#webpage\",\"url\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/\",\"name\":\"Brevetti farmaceutici, deroga al certificato complementare di protezione\",\"isPartOf\":{\"@id\":\"https:\/\/www.sib.it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#primaryimage\"},\"datePublished\":\"2019-05-21T13:57:46+00:00\",\"dateModified\":\"2019-05-22T08:06:22+00:00\",\"author\":{\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\"},\"description\":\"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sib.it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brevetti farmaceutici: in vigore entro il 1 luglio 2019 la deroga al certificato complementare di protezione\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\",\"name\":\"Laura Ercoli\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"caption\":\"Laura Ercoli\"},\"url\":\"https:\/\/www.sib.it\/en\/author\/lercoli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brevetti farmaceutici, deroga al certificato complementare di protezione","description":"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/","og_locale":"en_US","og_type":"article","og_title":"Brevetti farmaceutici, deroga al certificato complementare di protezione","og_description":"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.","og_url":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/","article_published_time":"2019-05-21T13:57:46+00:00","article_modified_time":"2019-05-22T08:06:22+00:00","og_image":[{"width":424,"height":283,"url":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg","type":"image\/jpeg"}],"twitter_card":"summary","twitter_misc":{"Written by":"Laura Ercoli","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.sib.it\/#website","url":"https:\/\/www.sib.it\/","name":"","description":"Intellectual Property since 1882","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sib.it\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#primaryimage","inLanguage":"en-US","url":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg","contentUrl":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg","width":424,"height":283,"caption":"deroga al certificato complementare di protezione"},{"@type":"WebPage","@id":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#webpage","url":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/","name":"Brevetti farmaceutici, deroga al certificato complementare di protezione","isPartOf":{"@id":"https:\/\/www.sib.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#primaryimage"},"datePublished":"2019-05-21T13:57:46+00:00","dateModified":"2019-05-22T08:06:22+00:00","author":{"@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b"},"description":"E' ormai definitivo il testo del nuovo regolamento che deroga al certificato complementare di protezione: entrata in vigore prevista entro il 1 luglio 2019.","breadcrumb":{"@id":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sib.it\/flash-news\/brevetti-farmaceutici-in-vigore-entro-il-1-luglio-2019-la-deroga-al-certificato-complementare-di-protezione\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sib.it\/"},{"@type":"ListItem","position":2,"name":"Brevetti farmaceutici: in vigore entro il 1 luglio 2019 la deroga al certificato complementare di protezione"}]},{"@type":"Person","@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b","name":"Laura Ercoli","image":{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","caption":"Laura Ercoli"},"url":"https:\/\/www.sib.it\/en\/author\/lercoli\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/9863"}],"collection":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/comments?post=9863"}],"version-history":[{"count":7,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/9863\/revisions"}],"predecessor-version":[{"id":9878,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/9863\/revisions\/9878"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media\/7011"}],"wp:attachment":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media?parent=9863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/categories?post=9863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/tags?post=9863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}